Results 11 to 20 of about 492,012 (208)

Tumor Necrosis Factor Alpha Signaling and Organogenesis [PDF]

Frontiers in Cell and Developmental Biology, 2021
Tumor necrosis factor alpha (TNF-α) plays important roles in processes such as immunomodulation, fever, inflammatory response, inhibition of tumor formation, and inhibition of viral replication.
Kai You, Hui Gu, Zhengwei Yuan, Xuewen Xu, Xuewen Xu   +4 more
doaj   +3 more sources

The concentration of tumor necrosis factor alpha in periapical lesions [PDF]

Stomatološki glasnik Srbije, 2014
Introduction. The balance between proinflammatory and anti-inflammatory cytokines plays an important role in the pathogenesis of chronic periapical lesions.
Popović Jelena, Cvetković Tatjana, Džopalić Tanja, Mitić Aleksandar, Nikolić Marija, Barac Radomir, Živković Slavoljub   +6 more
doaj   +4 more sources

Implication of Tumor Necrosis Factor - Alpha in Preeclampsia [PDF]

Applied Medical Informatics, 2008
Introduction: Preeclampsia is an exacerbation of a generalized inflammatory response, physiologically present in the third trimester of pregnancy.Aim: The aim of the study consists in the evaluation of proinflammatory cytokine TNF-α in the context of ...
Dan MIHU, Nicolae COSTIN, Ligia Daniela BLAGA, Septimiu CIUCHINĂ, Raluca Bogdana POP   +4 more
doaj   +2 more sources

Tumor necrosis factor alpha in sleep regulation

Sleep Medicine Reviews, 2018
This review details tumor necrosis factor alpha (TNF) biology and its role in sleep, and describes how TNF medications influence sleep/wake activity. Substantial evidence from healthy young animals indicates acute enhancement or inhibition of endogenous brain TNF respectively promotes and inhibits sleep.
Rockstrom, Matthew D, Chen, Liangyu, Taishi, Ping, Nguyen, Joseph T, Gibbons, Cody M, Veasey, Sigrid C, Krueger, James M   +6 more
openaire   +6 more sources

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis

Therapeutics and Clinical Risk Management, 2008
José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-CentenoUnit of Autoimmune Systemic Diseases, Hospital Clinico San Cecilio, Granada, SpainAbstract: Sarcoidosis is a chronic multisystem disease of unknown ...
José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-Centeno   +2 more
doaj   +5 more sources

Serum tumor necrosis factor alpha increased during remission with Etanercept [PDF]

Pediatric Rheumatology Online Journal, 2011
Miu Nicolae, Bolba Claudia, Samasca Gabriel, Spirchez Mihaela   +3 more
doaj   +2 more sources

Comparative Analysis of TNF-alpha, TNF-R1, and TNF-R2 in Patients with Low-impact Fractures Due to Osteoporosis [PDF]

Revista Brasileira de Ortopedia, 2023
Objective To analyze the serum levels of TNF-alpha and its TNF-R1 and TNF-R2 receptors in the blood of patients with low-impact fractures due to osteoporosis, comparing between genders and with healthy patients. Methods The present study was conducted
Abel Oliveira Marques Teixeira, Virmondes Rodrigues-Júnior, Bárbara Rocha Rodrigues, Danila Malheiros Souza, Leonardo Franco Pinheiro Gaia, Denise Bertulucci Rocha Rodrigues   +5 more
doaj   +1 more source

Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease : a prospective cohort study [PDF]

, 2015
Background : Soluble tumor necrosis factor receptors 1 (sTNFR1) and 2 (sTNFR2) have been associated to progression of renal failure, end stage renal disease and mortality in early stages of chronic kidney disease (CKD), mostly in the context of diabetic ...
AS Levey, C Obregon, CL Meuwese, D Aderka, D Aderka, DE Weiner, DV Barreto, EL Knight, Eva Schepers, FI Hawari, Francis Verbeke, G Tripepi, Griet Glorieux, JF Leeuwenberg, JK Pinckard, JM Luna, KJ Van Zee, L Cabal-Hierro, L Nilsson, Leighton R James, M Goicoechea, M Tonelli, M Valgimigli, MA Niewczas, MG Shlipak, MHA Bemelmans, Nathalie Neirynck, PJ Saulnier, Raymond Vanholder, RB Schnabel, S Soriano, S Xanthoulea, SJ Levine, T Gohda, T Kohno, T Ueland, V Panichi   +36 more
core   +14 more sources

Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials

Frontiers in Pharmacology, 2023
Objective: Tumor necrosis factor alpha inhibitors (TNFi) have shown substantial efficacy in alleviating and treating ankylosing spondylitis (AS). However, the heightened interest is accompanied by concerns over adverse events.
Haihuan Feng, Haihuan Feng, Ying Zhao, Weihong Kuang, Yanping Dai, Xiaobo Cen, Feng Qin, Feng Qin   +7 more
doaj   +1 more source

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases

Neural Regeneration Research, 2022
Inflammatory processes and proinflammatory cytokines have a key role in the cellular processes of neurodegenerative diseases and are linked to the pathogenesis of functional and mental health disorders.
Fatemeh Zahedipour, Seyede Atefe Hosseini, Neil C Henney, George E Barreto, Amirhossein Sahebkar   +4 more
doaj   +1 more source